Rockwell Medical, Inc.
Reports in 10d· 2026-05-07
-26.5% · 90d
$0.85
-0.03 (-3.09%)
After-Hours $0.85(+0.00)
News
(1)April 2026
RMTI shareholders vote on reverse stock split and board changes
RMTIROCKWELL MEDICAL, INC.
# 📋 What This Document Is 📝 This document is a Preliminary Proxy Statement (Schedule 14A), which is a formal report filed with the SEC. Think of it as the comprehensive instruction manual for shareholders, explaining everything that will be decided at the company's annual meeting. 📖 The purpose
Read summaryView on SEC EDGAR
Peers in Drug Manufacturers - Specialty & Generic
TAK#1
Takeda Pharmaceutical Company Limited
$57.78B-1.07%
ZTS#2
Zoetis Inc.
$50.46B+0.20%
HLN#3
Haleon plc
$43.61B+0.40%
TEVA#4
Teva Pharmaceutical Industries Limited
$36.05B+1.44%
UTHR#5
United Therapeutics Corporation
$25.19B-1.19%
VTRS#6
Viatris Inc.
$15.85B+0.29%
RGC#7
Regencell Bioscience Holdings Limited
$13.93B-2.46%
NBIX#8
Neurocrine Biosciences, Inc.
$13.21B-1.13%
ELAN#9
Elanco Animal Health Incorporated
$11.66B-0.59%
RDY#10
Dr. Reddy's Laboratories Limited
$10.92B+0.15%